These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21034717)

  • 1. [Primary cutaneous CD30+ large T-Cell lymphoma with lymph node and cerebral metastases].
    Simal E; Hörndler C; Porta N; Baldellou R
    Actas Dermosifiliogr; 2010 Nov; 101(9):810-2. PubMed ID: 21034717
    [No Abstract]   [Full Text] [Related]  

  • 2. CD8-positive primary cutaneous anaplastic large cell lymphoma presenting as multiple scrotal nodules and plaques.
    Xu H; Qian J; Wei J; Zhao Y; Zhou C; Chen D; Zhang J
    Eur J Dermatol; 2011; 21(4):609-10. PubMed ID: 21680287
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained response of primary cutaneous CD30 positive anaplastic large cell lymphoma to bexarotene and photopheresis.
    Sheehy O; Catherwood M; Pettengell R; Morris TC
    Leuk Lymphoma; 2009 Aug; 50(8):1389-91. PubMed ID: 19544141
    [No Abstract]   [Full Text] [Related]  

  • 4. Syndrome of inappropriate antidiuretic hormone secretion associated with primary cutaneous anaplastic large cell lymphoma.
    Hirata Y; Yokote T; Nishiwaki U; Tsuji M; Hanafusa T
    Br J Haematol; 2012 May; 157(4):412. PubMed ID: 22409317
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
    Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
    Isogai R; Fukao M; Kawada A
    J Dermatol; 2007 Aug; 34(8):556-60. PubMed ID: 17683387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic cerebellar degeneration: initial presentation in a patient with anaplastic T-cell lymphoma, associated with ichthyosiform cutaneous lesions.
    Rodis DG; Liatsos GD; Moulakakis A; Pirounaki M; Tasidou A
    Leuk Lymphoma; 2009 Aug; 50(8):1369-71. PubMed ID: 19544138
    [No Abstract]   [Full Text] [Related]  

  • 8. A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.
    Sridevi HB; Shanthala PR; Raghuveer CV; Prabhu AK; Akbar JK; Shivaprasad GS; Suresh PK; Navani S
    J Cancer Res Ther; 2015; 11(3):656. PubMed ID: 26458652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitrochlear lymph node: an unusual physical finding in lymphoma with important clinical significance.
    Goli AK; Koduri M; Goli SA; Byrd RP; Roy TM
    Tenn Med; 2006 Sep; 99(9):35-6. PubMed ID: 17225779
    [No Abstract]   [Full Text] [Related]  

  • 10. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.
    Osorio S; Bernis C; de La Cámara R
    Haematologica; 2002 Feb; 87(2):ELT05. PubMed ID: 11836182
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
    Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
    Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.
    Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M
    Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
    Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
    Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary hepatic non-Hodgkin's lymphoma].
    De la Maya MD; Escalante R; Torre A; Urdambidelus C
    Sangre (Barc); 1999 Jun; 44(3):242. PubMed ID: 10481592
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary cutaneous anaplastic large-cell lymphoma.
    Newlove T; Loyd A; Patel R; Jelinek J; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):2. PubMed ID: 21163153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
    Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
    J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intestinal lymphoma. A report of 2 cases].
    Breda E; Temperilli L
    Minerva Med; 1992 Apr; 83(4):223-5. PubMed ID: 1374168
    [No Abstract]   [Full Text] [Related]  

  • 19. Castleman disease and adenocarcinoma.
    Megalakaki A; Evmorfiadis I; Stamouli M; Zakopoulou N; Iacovidou I
    J BUON; 2011; 16(4):781-2. PubMed ID: 22331742
    [No Abstract]   [Full Text] [Related]  

  • 20. A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
    Mead GM; Bleehen NM; Gregor A; Bullimore J; Shirley D; Rampling RP; Trevor J; Glaser MG; Lantos P; Ironside JW; Moss TH; Brada M; Whaley JB; Stenning SP
    Cancer; 2000 Sep; 89(6):1359-70. PubMed ID: 11002232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.